FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
Pharmacy Times
JUNE 10, 2025
Azurity Pharmaceuticals announces the FDA approval of XIFYRM™ (meloxicam injection) for the management of moderate-to-severe pain in adults. Seminars in Arthritis and Rheumatism. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004.
Let's personalize your content